This inventor holds 4 USPTO granted patents. Top assignees: Terumo Kabushiki Kaisha, Terumo Corporation. Active years: 1988-1990.
Company Filing History:
Years Active: 1988-1990
Title: **The Innovative Journey of Shin Hattori**
Introduction
Shin Hattori is a prominent inventor based in Yokohama, Japan, with a remarkable portfolio comprising four patents. His contributions to the field of pharmaceuticals, particularly in developing antiallergic agents, highlight his innovative spirit and dedication to advancing science.
Latest Patents
Among his latest patents, Shin Hattori has disclosed novel amide derivatives that exhibit therapeutic potential. For instance, the patent describing "Amide Derivatives and Antiallergic Agents Containing the Same" reveals compounds such as 1-[2-[5-(3-methoxy-4-ethoxycarbonyloxyphenyl)-2,4-pentadienoyl]-aminoethyl]-4-benzhydroxypiperidine and 1-[2-[3-(3-methoxy-4-ethoxycarbonyloxyphenyl)-2-propenoyl]-4-benzhydroxypiperidine. These innovative compounds are evaluated for their efficacy as antiallergic agents. Another significant patent is "Amide Derivatives and 5-Lipoxygenase Inhibitors Containing the Same," which presents derivatives like N-cyclohexyl-N-methyl-(2-(3-(3-methoxy-4-hydroxyphenyl)-2-(propenoylamino)-3,5-dibromobenzyl)amine, showcasing their applications in reducing allergic responses through 5-lipoxygenase inhibitory activity.
Career Highlights
Shin Hattori's career is marked by his association with notable companies such as Terumo Kabushiki Kaisha and Terumo Corporation. His work in these organizations has enabled him to contribute significantly to the pharmaceutical field, focusing on innovative solutions for allergy management.
Collaborations
Throughout his career, Shin Hattori has collaborated with esteemed colleagues such as Makoto Takai and Toshio Wakabayashi. These partnerships have undoubtedly enriched his research and development processes, allowing for a synergistic approach to innovation in the medical sciences.
Conclusion
Shin Hattori's commitment to advancing pharmaceutical sciences through innovative patenting reflects his expertise and passion for the field. As he continues to develop new compounds with potential therapeutic applications, his work remains vital in addressing the challenges of allergic conditions.